ReelReactor is transforming biologics and chemical manufacturing with a continuous micro-batch reactor — bringing the precision of flow chemistry to biology. Every micro-batch reacts under identical, gently mixed conditions, delivering consistent quality, higher throughput & simpler GMP validation for cell and gene therapy, viral vector, and biologics production.

10X Science builds an AI-native platform for protein characterization, automating analysis pharma and biotech teams use to advance drug candidates. Rooted in Carolyn Bertozzi's Nobel Prize-winning Stanford lab, the company is backed by Initialized Capital and Y Combinator and already serves large pharmaceutical customers.

A biotechnology company advancing next-generation RNA synthesis and RNA-based solutions, with a manufacturing platform designed to make therapeutic RNA production more scalable and more broadly applicable across a range of RNA-based applications.

A drug discovery company using machine learning and large-scale biological data to uncover new disease targets faster than traditional R&D approaches allow, combining human genetics, single-cell, and functional data to build detailed maps of disease biology.

A materials science company developing low-carbon, temperature-responsive materials for cooling — starting with commercial greenhouse applications, where its technology has demonstrated meaningful gains in crop yield, with further applications in building cooling systems.

A medical device company focused on making advanced diagnostics accessible outside the hospital, starting with a noninvasive, cuff-free device for continuous blood pressure monitoring in home, clinical, and field settings.

A life sciences instrumentation company building compact, affordable benchtop devices for single-molecule spectroscopy — bringing high-throughput, high-precision drug discovery tools to labs that couldn't previously access them.

A deep-tech company applying advanced artificial intelligence to personalized medicine, combining minimally invasive testing with computational health monitoring to build a detailed, ongoing picture of an individual's health.

Harbinger Health develops liquid biopsy blood tests to detect early signs of cancer, powered by its proprietary data and AI platform. The company's multi-cancer detection platform is designed to improve early screening and reduce false results.

Arctos Partners is a leading sports investment firm with stakes across MLB, NBA, NHL, NFL, and global soccer, including Fenway Sports Group, the Golden State Warriors, and Liverpool FC. Camillus Capital is invested in Arctos's American football fund, providing indirect exposure to its growing portfolio of NFL franchise stakes.